<scp>Cryo‐EM</scp> structures of tau filaments from <scp>SH‐SY5Y</scp> cells seeded with brain extracts from cases of Alzheimer's disease and corticobasal degeneration

Airi Tarutani, Sofia Lövestam, Xianjun Zhang, Abhay Kotecha, Andrew Robinson, David M. A. Mann, Yuko Saito, Shigeo Murayama, Taisuke Tomita, Michel Goedert, Sjors H. W. Scheres, Masato HasegawaFEBS 2023 · DOI

TL;DR

This study uses cryo-electron microscopy (cryo-EM) to reveal the atomic structures of tau filaments formed in cultured human cells (SH-SY5Y) after being "seeded" with tau aggregates from Alzheimer's disease (AD) and corticobasal degeneration (CBD) brains. While the seeded filaments in cells partially resemble the original brain seeds, they are not identical, suggesting that cellular environments influence the final structure of these disease-associated protein aggregates.

What Problem Does This Paper Address?

Neurodegenerative diseases like Alzheimer's and corticobasal degeneration are characterized by the accumulation of misfolded tau protein into amyloid filaments. A key hypothesis is that these filaments propagate through "templated seeding," where existing misfolded proteins act as templates to induce misfolding in healthy proteins. To study this, researchers often use cell-based models where cultured cells are exposed to "seeds" from diseased brains. However, it's unclear how faithfully these cell-based models replicate the exact structures of the original tau seeds. This paper addresses this by determining the high-resolution structures of tau filaments formed in a common cell model (SH-SY5Y) after seeding with AD and CBD brain extracts, and comparing them directly to the structures of the original seeds.

Methods

The core technique employed is cryo-electron microscopy (cryo-EM). This allows researchers to determine the three-dimensional structure of biological molecules at near-atomic resolution.

Here's a breakdown of the key steps:

  • Seeding: Sarkosyl-insoluble fractions (enriched for tau filaments) were prepared from postmortem brains of individuals with AD and CBD. These fractions served as the "seeds."
  • Cell Culture and Transfection: Human neuroblastoma SH-SY5Y cells were cultured and transiently transfected to express either N-terminally HA-tagged 1N3R or 1N4R human tau isoforms.
  • Seeded Aggregation: The SH-SY5Y cells expressing tau were exposed to the prepared brain-derived tau seeds. This process aims to induce the cells to form new tau filaments templated by the seeds.
  • Filament Isolation: Tau filaments formed within the seeded cells were isolated using sarkosyl extraction.
  • Cryo-EM Data Collection and Reconstruction: The isolated filaments were plunge-frozen onto grids and imaged using a Titan Krios electron microscope. Sophisticated image processing and helical reconstruction algorithms (implemented in RELION) were used to generate 3D density maps of the filaments.
  • Model Building: Atomic models of the tau filaments were built into the cryo-EM density maps using computational tools like ISOLDE and Phenix.
  • Structural Comparison: The structures of the seeded filaments were compared to known structures of tau filaments from AD (paired helical filaments - PHFs, and straight filaments - SFs) and CBD.

The use of cryo-EM for amyloid filament structures is standard in the field, but the application to cell-based seeded aggregates and direct comparison to brain-derived seeds at this resolution is a significant contribution.

Datasets

The primary "datasets" in this study are the sarkosyl-insoluble fractions derived from postmortem human brains of individuals diagnosed with Alzheimer's disease (AD) and corticobasal degeneration (CBD). These served as the tau seeds.

The study also references and compares its findings to previously determined cryo-EM structures of tau filaments from AD and CBD, which are available in public databases like the Protein Data Bank (PDB) and Electron Microscopy Data Bank (EMDB).

No new benchmarks or large-scale datasets were introduced by this paper.

Key Insights and Ideas

  • Cellular Templating is Imperfect: The most striking finding is that tau filaments formed in SH-SY5Y cells, even when seeded with brain extracts, are structurally similar but not identical to the original brain seeds. This challenges the assumption that cell-based seeding perfectly replicates the seed structure.
  • Structural Divergence: The seeded filaments showed subtle but distinct differences in their folds and the arrangement of amino acid residues compared to the original AD and CBD tau seeds. This suggests that the cellular environment, including the presence of other cellular components or the specific tau isoforms expressed, influences the final filament structure.
  • Two Types of CBD-Seeded Filaments: When seeding with CBD extracts, two distinct filament structures were resolved in the SH-SY5Y cells. This highlights the complexity of tau pathology and how different structural polymorphs can arise.
  • Implications for Disease Mechanisms: Understanding how cellular environments modify tau structures is crucial for deciphering the mechanisms of tau propagation and the diversity of tauopathies. This work provides a high-resolution view of this process.
  • Tau Isoform Specificity: The study noted that seeding with AD brain extracts was more efficient with 1N3R tau expression than 1N4R tau, suggesting that the specific tau isoforms present in the cell can influence the seeding process.

Key Results

  • AD Seeded Filaments: Cryo-EM analysis revealed a single filament type in SH-SY5Y cells seeded with AD brain extracts, expressing HA-1N3R tau. This filament had a C-shaped fold and closely resembled the Alzheimer tau fold of paired helical filaments (PHFs) and straight filaments (SFs), but with minor conformational differences.
  • CBD Seeded Filaments: Two filament types were resolved in SH-SY5Y cells seeded with CBD brain extracts, expressing HA-1N4R tau. Both types shared a common core structure similar to known CBD tau folds but differed in their carboxy-terminal regions.
  • Structural Similarities and Differences: While seeded structures showed significant similarity to the brain seeds, specific differences were observed in the conformation of certain motifs (e.g., the 332PGGG335 motif in AD-seeded filaments) and in the presence/absence of additional densities, suggesting variations in inter-protofilament interactions or the incorporation of cellular components.

Limitations and Future Work

  • Cell Model Limitations: The authors acknowledge that undifferentiated SH-SY5Y cells are a simplified model and may not fully represent the complexity of neuronal or glial cells in the brain. Future work should investigate seeding in a wider variety of cell types, including differentiated neurons and glial cells.
  • Isoform Specificity: The observation that AD seeding was more efficient with 1N3R tau than 1N4R tau warrants further investigation into the role of specific tau isoforms in templated aggregation within different cell types.
  • Nature of Additional Densities: The additional densities observed in the seeded structures, particularly in the CBD-seeded filaments, are of unknown molecular composition. Identifying these components could provide further insights into cellular interactions during tau aggregation.
  • Replication of Seed Structures: The study raises the question of whether perfect replication of seed structures is necessary for templating to be relevant. Future experiments should explore the functional consequences of these structural differences.
  • Broader Disease Spectrum: The authors suggest extending these studies to brain extracts from other tauopathies to understand the structural diversity of seeded tau filaments across different diseases.

Summary updated

Abstract

The formation of amyloid filaments through templated seeding is believed to underlie the propagation of pathology in most human neurodegenerative diseases. A widely used model system to study this process is to seed amyloid filament formation in cultured cells using human brain extracts. Here, we report the electron cryo-microscopy structures of tau filaments from undifferentiated seeded SH-SY5Y cells that transiently expressed N-terminally HA-tagged 1N3R or 1N4R human tau, using brain extracts from individuals with Alzheimer's disease or corticobasal degeneration. Although the resulting filament structures differed from those of the brain seeds, some degrees of structural templating were observed. Studying templated seeding in cultured cells, and determining the structures of the resulting filaments, can thus provide insights into the cellular aspects underlying neurodegenerative diseases.
BibTeX
@inproceedings{tarutani2023scp,
  author = {Airi Tarutani and Sofia Lövestam and Xianjun Zhang and Abhay Kotecha and Andrew Robinson and David M. A. Mann and Yuko Saito and Shigeo Murayama and Taisuke Tomita and Michel Goedert and Sjors H. W. Scheres and Masato Hasegawa},
  title = {{<scp>Cryo‐EM</scp> structures of tau filaments from <scp>SH‐SY5Y</scp> cells seeded with brain extracts from cases of Alzheimer's disease and corticobasal degeneration}},
  booktitle = {FEBS},
  year = {2023},
  doi = {10.1002/2211-5463.13657},
}
Figure